Please login to the form below

Not currently logged in
Email:
Password:

JE vaccine approved for marketing in Europe

For the first time the EMEA has granted marketing authorisation for a vaccine for the prevention of Japanese Encephalitis in adults. Novartis Vaccines will market the product as Ixiaro in Europe

For the first time the European Medicines Agency (EMEA) has granted marketing authorisation for a vaccine for the prevention of Japanese Encephalitis (JE) in adults. Novartis Vaccines will market the product as Ixiaro in Europe.

JE, a mosquito-borne flaviviral infection, results in 10,000-15,000 deaths annually and is a potential threat for travellers to Asia. Until now there has been no licensed JE vaccine in Europe, although imported vaccines have been available on a named patient basis. The risk of contracting JE from a short urban visit to Asia is generally given as “extremely low”. However, there have been reported cases among short-stay holiday-makers. The risks for long stays in rural areas during transmission season are higher. 

Dr Andrin Oswald, CEO of Novartis Vaccines and Diagnostics, said: "Asia is a very popular travel destination for Europeans. Since JE is spread by mosquitoes, the threat to travellers is unpredictable and may be underestimated. Vaccination is the most effective preventive measure against the disease and this vaccine will help travellers from Europe to Asia."

JE is prevalent in countries such as India, parts of China, Thailand, Indonesia, Cambodia and Vietnam.

27th April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics